ArticleCancer medicine2018

Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.

Xianqiong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.